Details for New Drug Application (NDA): 061395
✉ Email this page to a colleague
The generic ingredient in AMPICILLIN SODIUM is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
Summary for 061395
Tradename: | AMPICILLIN SODIUM |
Applicant: | Sandoz |
Ingredient: | ampicillin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 061395
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 061395 | ANDA | Hospira, Inc | 0409-3718 | 0409-3718-01 | 10 VIAL, GLASS in 1 PACKAGE (0409-3718-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (0409-3718-10) |
AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 061395 | ANDA | Sandoz Inc | 0781-3400 | 0781-3400-95 | 10 VIAL, GLASS in 1 PACKAGE (0781-3400-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS (0781-3400-78) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 125MG BASE/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | No |
Complete Access Available with Subscription